Number of items: 1.
Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients. (2025)
L. Sharma,
V. Balaji,
A. Katumba,
E. Mohan,
I. Mporas,
D. Alrifai,
J. Chow,
T. Sevitt,
K. Nathan,
R. Shah,
J.S.C. Waters
and
S. Adeleke
This list was generated on Thu Apr 16 02:16:30 2026 BST.